Fibrin Sealants Market Report 2024

This Fibrin Sealants market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The fibrin sealants market size has grown strongly in recent years. It will grow from $1 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The historical growth can be attributed to several factors, the expansion of medical tourism, improvements in healthcare infrastructure, an increase in elective surgical procedures, a higher prevalence of chronic diseases, and a growing demand for rapid hemostasis solutions.

The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.49 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The anticipated growth during the forecast period is driven by several factors, a rising number of cosmetic surgeries, an increasing geriatric population, a growing number of coronary artery bypass grafting (CABG) procedures, a higher incidence of blood-related disorders, and an uptick in dental surgeries. Key trends expected include advancements in technology, development of advanced hemostatic technologies, personalized medicine, digital health innovations, and the use of robotic-assisted surgeries.

The growth of the fibrin sealants market is anticipated to be driven by the increasing number of cosmetic surgeries. Cosmetic surgeries, which focus on enhancing or altering an individual’s appearance, are on the rise due to societal focus on aesthetics, advancements in surgical techniques, and greater access to minimally invasive procedures. Fibrin sealants are used in cosmetic surgeries to promote quicker wound healing, reduce bleeding, and minimize scarring, thereby improving surgical outcomes and patient recovery. For example, CosmetAssure reported in September 2023 that liposuction was the most popular plastic surgery procedure in 2023, with 347,782 procedures performed, reflecting a 7% increase from 2022. Additionally, tummy tucks saw a 5% rise, with 170,110 procedures carried out. This increase in cosmetic surgeries is boosting the demand for fibrin sealants.

Companies in the fibrin sealants market are developing hemostatic agents to rapidly control bleeding upon contact. Hemostatic agents are substances used to stop bleeding by encouraging blood clotting at wound or surgical sites. For instance, in February 2022, Swasth Kare, an India-based manufacturer of hemostatic agents, introduced SeraSeal, developed by Wortham Laboratories, also based in India. SeraSeal is a fibrin sealant designed to stop bleeding almost instantly, even in cases of arterial hemorrhage. Its rapid action is crucial in emergencies, and its translucent quality allows surgeons to clearly see the bleeding site, aiding in better decision-making during procedures.

In July 2024, Corza Medical, a US-based company specializing in innovative surgical technologies, acquired Takeda’s TachoSil Manufacturing Operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to enhance service levels and global customer support. Takeda, a pharmaceutical company based in Japan, is involved in the development and production of fibrin sealants.

Major players in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., and Cohesion Technologies Inc.

North America was the largest region in the fibrin sealants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibrin sealants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Fibrin sealants, also known as fibrin glues or fibrin tissue adhesives, are specialized medical products used to facilitate blood clotting and tissue healing. They consist of two key components derived from human or animal blood, fibrinogen, a protein involved in blood clot formation, and thrombin, an enzyme that converts fibrinogen into fibrin, the primary substance in blood clots. These sealants are commonly employed during surgeries to manage bleeding, particularly in delicate or difficult-to-reach areas where traditional methods such as sutures or cauterization may not be effective.

The main types of fibrin sealants include liquid, patch, and powder forms. Liquid fibrin sealants are solutions of fibrinogen and thrombin that, when mixed, form a fibrin clot. These sealants are applied during surgical procedures to control bleeding and enhance tissue adhesion, with methods of application such as dripping or spraying for precise delivery to the affected area. Technologies used in the production of fibrin sealants include autologous donation, viral inactivation, and recombinant production, among others. Fibrin sealants are used in a variety of applications, including general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgeries, ophthalmic surgeries, and transplant surgery, and are utilized in hospitals, ambulatory surgical centers, and other healthcare facilities.

The fibrin sealants market research report is one of a series of new reports that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.